ATM and cancer: Combined application of ATM and Chk1 inhibitors prompted not only robust apoptotic cell death in orthotopic xenograft tumors with Onc-p53, but also a near-complete elimination of cancer cells expressing Onc-p53 in lung orthotopic tumors (Fig. 8).